1. Karancin na'urorin gano acid nucleic zai zama matsala a duniya.

2. Kamfanonin IVD na kasar Sin suna da ikon zuwa kasashen waje don yin gogayya da manyan kamfanoni na duniya.

3, don kasuwar gwajin reagent hargitsi, aikin hukuma na sarrafa magunguna!

Yawancin kamfanoni na IVD sun sami rukunin farko na takaddun shaida na ƙasashen waje don sabbin samfuran su na corona

Ya zuwa yanzu, Hukumar Kula da Abinci da Magunguna ta Jiha ta amince da 20 daga - na - na'urorin gano jikin a cikin gaggawa, gami da na'urorin gano ƙwayoyin acid guda 12 da na'urorin gano ƙwayoyin cuta guda 8.
A cewar rahoton bincike na Securities na yammacin kasar Sin, duniya na amfani da na'urorin gwajin kwayoyin acid guda 500,000 zuwa 700,000 a kowace rana. Karancin na'urorin gwajin acid nucleic zai zama matsala a duniya, yayin da ake sa ran bukatar manyan na'urori masu inganci da aka yi a kasar Sin za su kasance da yawa.

Rahoton rahoton bincike ya nuna cewa a kalla kasashe 26 ne suka mika odar samar da kayayyaki ga kasar Sin, tare da ba da odar kayayyaki sama da miliyan 15. A cikin wata sanarwa da ta fitar a ranar Talata, AMA ta ce "Matsalar karancin kayan gano coronavirus da kayan kariya na mutum har yanzu ba a warware su ba."

Kwanan nan, da dama na IVD sha'anin sabon kambi kayayyakin ta farkon kasashen waje takardar shaida a kasuwa. Daga cikin kamfanonin da aka jera, akalla kamfanoni 9 da aka jera, da suka hada da Meikang Biotechnology, Peoson Biotechnology, Cape Biotechnology, Anke Biotechnology, Daan Genomics, Wanfu Biotechnology, Mike Biotechnology da Hangzhou Realytech, sun yi ikirarin cewa kayayyakinsu sun samu takardar shedar EU CE.

AusDiagnostics inc., Roche Diagnostics Inc., Vivacheck Inc., Zhijiang Group LTD., CTK Group LTD. (TGA) da Hollogier Group Inc. (TGA) a ranar Asabar, Maris 22, bisa ga Hukumar Kula da Magunguna ta Australiya (TGA). Hangzhou Otai, Vivacheck da Shanghai Zhijiang kamfanoni ne na IVD na cikin gida.

A cikin Amurka, bisa ga gidan yanar gizon hukuma na FDA, ainihin - kayan kyalli na RT - Kayan PCR da BGI ta samar don gano SARS - 2019 - NCOV FDA ta amince da ita kuma ana iya sanya shi a hukumance cikin rigakafin cutar da sarrafawa a cikin Amurka. Wannan shine samfurin Sinanci na farko da ya wuce izinin gaggawa na FDA.
A hakika, kamfanonin IVD na kasar Sin suna da ikon zuwa kasashen waje don yin gogayya da kamfanoni masu daraja na duniya.

Hangzhou Realytech ya wuce takaddun FDA. Adadin gano coronavirus labari ya yi yawa. Da fatan za a ji daɗin tuntuɓar mu idan kuna buƙatasayan coronavirus gaggawa gano reagent da yawa.